Centrexion’s $67M Series D round to fund Phase 3 pain studies
Despite being just four years old, Centrexion, which just raised $67 million, is building a significant pipeline of non-opioid, non-steroidal pain medications.
2 contrasting medtech approaches to deal with chronic pain and avoid opioids
Medtronic and SPR Therapeutics are treating chronic pain but while the former has adopted a permanent, implantable neuromodulation treatment, the latter is going the temporary wearable route.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Health IT startup using analytics to assess pain treatment, costs raises $16.5M
The funding will be used to ramp up Axial's customer base and double the size of the 50-staff workforce over the next 12-18 months, Axial Healthcare CEO John Donahue said in a phone interview.
Boston Scientific acquires RF ablation firm to treat chronic pain
Cosman Medical, which makes RF generators and electrodes among other things, will become part of Boston Scientific's neuromodulation business.
Hollywood on patients: Noble suffering is OK, but angry and in pain is not
The list of 2015 Oscar nominees has already been criticized a lot. Too white, too male and no nominations for the Lego Movie or Selma. They also ignored “Cake” that stars Jennifer Aniston. She is a woman who lives in chronic pain. Apparently she is also a jerk, as she gets kicked out of a […]
Neurometrix receives FDA OK for OTC use of its wearable chronic pain gadget
Massachusetts-based Neurometrix just received 510(k) clearance from the Food and Drug Administration for over-the-counter use of its wearable gadget that treats chronic pain. The lightweight device, which is still under development and projected for commercial launch next year, emits electric jolts to the wearer. It is modeled after Sensus, the company’s device that treats pain associated with […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees
Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to begin a clinical study on its technology for intractable limb pain management for amputees. According to the company website, the Altius System High Frequency Nerve Block technology “consists of an electrode (also known as a lead) placed around a peripheral […]